Ed Yong, a science writer for the Atlantic, has a talent for getting to the heart of the matter. During the coronavirus pandemic, he’s often seemed a step or two ahead of his colleagues. His trenchant reporting has landed him a bunch of awards: the Pulitzer Prize in...
Suzanne Vernon’s interest in pathogens and post-infectious diseases goes back to when, as a 20-year-old, she landed a work-study job at the CDC’s Division of Vector-Borne Diseases while an undergraduate at Colorado State University. Ten years later with...
How long, indeed? Some people with long COVID are now entering their third miserable year with the illness. They can’t be happy. Their doctors are at a loss. Treatment trials are underway, but most are too small or poorly run to light up the medical world. The...
With its more remarkable funding, the NIH should be leading the hunt to solve long COVID. Thus far, though, it’s in the rear of the pack. The NIH’s history with post-infectious diseases like chronic fatigue syndrome (ME/CFS) carries so much baggage, and is...
Last week Health Rising highlighted one role that #MEAction, in its capacities as a superb communication resource, provides: outreach to the scientific community. Today we focus on a surprising side of MEAction: as a generator of scientific data. MEAction...
Avindra Nath reports the intensive NIH intramural ME/CFS study achieved its goal: finding consistent biological abnormalities that point to possible treatment options. You might be forgiven for thinking that #MEAction is “just” an advocacy organization....